Results 11 to 20 of about 211,324 (159)
TGF-β1/SMAD在糖尿病肾病中的作用机制与研究进展 [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2023 Diabetic nephropathy (DN) is a common complication of diabetes and a leading cause of end-stage renal disease. Transforming growth factor-β1 (TGF-β1)/SMAD signaling activation plays an important role in the onset and progression of DN.
Shao, Baoyi +4 more
core +2 more sources
Zhejiang Da Xue Xue Bao Yi Xue Ban糖尿病肾病是常见的糖尿病微血管并发症，也是糖尿病患者死亡的主要原因之一。铁死亡是一种铁依赖性调节性细胞死亡，其在糖尿病肾病的发生发展中具有一定作用。腺苷一磷酸活化的蛋白质激酶（AMPK）介导的铁死亡相关信号通路可以延缓糖尿病肾病的进程，但AMPK信号过度激活可能会诱导细胞发生自噬性死亡；激活核转录因子红系2相关因子（Nrf）2和血红素加氧酶（HO）-1介导的信号通路能够抑制细胞铁死亡并改善糖尿病肾病，但HO-1在铁死亡中的调节作用是双向的，激活HIF-1α/HO-1信号通路可能导致细胞内铁过载 ...
张 正东, 陈 秋, 刘 攀
core +2 more sources
Correlation of ACR and TcPO2 in diabetic kidney disease patients: A pilot study 糖尿病肾病患者尿白蛋白与肌酐比值和经皮氧分压的相关性:一项初步研究 [PDF]
Journal of Diabetes, Volume 15, Issue 6, Page 488-495, June 2023., 2023 Highlights Transcutaneous oxygen pressure (TcPO2) could be used to assess microcirculation, which revealed endothelial injury. As endothelial injury is a cause of albuminuria in diabetic kidney disease (DKD), albuminuria and creatinine (ACR) might be employed to assess microcirculation in DKD patients in rural hospital where TcPO2 is not available. Our
Jin Sun +7 more
wiley +2 more sources
Glomerular cell cross talk in diabetic kidney diseases 糖尿病肾病中肾小球细胞间的相互作用 [PDF]
Journal of Diabetes, Volume 14, Issue 8, Page 514-523, August 2022., 2022 Highlights Glomerular cell cross talk is essential for maintaining the glomerular filtration barrier. In‐depth exploration of intraglomerular signaling pathway changes during diabetic kidney disease may help discover new therapeutic targets. Abstract Diabetic kidney disease (DKD) is a severe microvascular complication of diabetes mellitus.
Ruixue Dong, Youhua Xu
wiley +2 more sources
Zhongshan Daxue xuebao. Yixue kexue ban, 2020 【目的】探讨 2 型糖尿病（T2DM）患者合并肾脏疾病的临床病理特点及预后。【方法】回顾性分析120 例尿检异常和（或）Scr 升高并接受肾活检的2 型糖尿病患者的临床病理资料，并进行了随访。肾脏结局的定义是接受肾脏替代治疗或进入到终末期肾病（ESRD）。Kaplan-Meier 分析用于比较肾存活率，Cox 比例风险分析用于进行糖尿病肾病（DN）和非糖尿病肾脏疾病（NDRD）进入 ESRD 的风险比较。【结果】120 例 2 型糖尿病患者中，肾穿刺确诊DN57 例，占47.5%；NDRD63 例 ...
李明 +5 more
doaj +1 more source
氯沙坦对糖尿病大鼠肾组织TIMP2 mRNA 表达的影响 [PDF]
Zhongshan Daxue xuebao. Yixue kexue ban, 2002 【目的】研究实验性糖尿病大鼠肾组织2 型金属蛋白组织抑制物(TIMP2)mRNA 表达的变化及氯沙坦对它的 影响。【方法】纯种雄性Wistar 大鼠分为3 组, 正常对照组(11 只), 糖尿病大鼠无干预组(11 只), 糖尿病大鼠氯沙坦(血管紧 张素Ⅱ1 型受体阻断剂)干预组(9 只)。链脲佐菌素制备糖尿病大鼠模型。饲养18 周后取出肾以RT-PCR 检测TIMP2 mRNA 表达, 电镜检测大鼠肾小球基底膜厚度及系膜基质密度(系膜基质面积/ 系膜面积);收集24 h 尿测定尿白蛋白排泄 ...
宛 霞, 黄湖辉, 李劲高
doaj +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1997 摘 要 研究37只病程1～ 6个月糖尿病及29只同龄对照大鼠血浆及肾组织肾素活性、ATⅡ 含量、肾组 织血管紧张素原基因m RN A表达水平等改变。发现仅在病程3个月时糖尿病鼠血浆ATⅡ 及肾组织血管紧张 素原mRN A表达水平升高,病程1～ 6个月糖尿病鼠肾组织ATⅡ 含量均升高。结果显示: 糖尿病鼠肾组织与血 浆肾素血管紧张素系统活性改变呈不平行现象; 肾组织肾素-血管紧张素系统活性增强可能是糖尿病肾病形成 及发展的重要因素之一。
杨荣泽 严 励 傅祖植 钟光恕 严 棠
doaj +1 more source
抑制 NAD(P)H 氧化酶表达和活性对大鼠糖尿病肾病的影响
Zhongshan Daxue xuebao. Yixue kexue ban, 2004 【目的】 探讨NAD(P)H氧化酶在糖尿病肾病发病中的作用和防治方法?【方法】 链脲佐菌素(STZ)诱导的大鼠糖尿病模型随机分为糖尿病组NAD(P)H氧化酶抑制剂apocynin治疗组(0.2 g·kg-1·d-1)和血管紧张素转换酶抑制剂福辛普利治疗组(10 mg· kg-1· d-1),疗程8周?用RT-PCR检测肾NAD(P)H氧化酶亚基p22phox mRNA表达;组织病理学检查观察肾病变程度;测定血肌酐(Scr)?内生肌酐清除率(Ccr)?24 h尿蛋白排泄量?肾质量指数等?【结果 ...
doaj +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 853-865, October 2023., 2023 Highlights Few studies have investigated the association of large‐scale biomarkers and pulse wave velocity (PWV) among diabetic patients. This study investigates the relationships of serum laboratory tests with PWV and explored the associations between PWV and all‐cause mortality among diabetic patients.
Yong‐Qi Liang +9 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 890-899, October 2023., 2023 Highlights Patients with type 2 diabetes (T2D) are prone to developing chronic diabetes‐related complications at the microvascular and macrovascular levels. The Computerized Nailfold Video‐Capillaroscopy (CNVC) provides specific information on both quantitative and qualitative characteristics of microvasculature at the level of fingers.
Giuseppe Lisco, Vincenzo Triggiani
wiley +1 more source